GUO Heng 1,2 , ZHU Shuaijie 1,2 , SHI Wei 1,2 , ZHANG Xiaoyu 1,2 , HUA Tianfeng 1,2 , YANG Min 1,2
  • 1. The Second Department of Intensive Care Unit, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;
  • 2. The Laboratory of Cardiopulmonary Resuscitation and Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;
YANG Min, Email: yangmin@ahmu.edu.cn
Lower respiratory tract infection; Disease burden; Aetiology; Risk factors
10.7507/1672-2531.202406146
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective The aim of this study was to assess the disease burden of non-COVID-19 lower respiratory infection (LRI) in China during the period 1990−2021, particularly during the period 2019−2021. Methods Data on the burden of disease for LRI in China were obtained from the GBD 2021 database. A Joinpoint regression model was used to describe the changes in disease burden trends of LRI in China from 1990 to 2021, and the results are presented in terms of average annual percentage change (AAPC). Results In 2021, the age-standardized incidence rate of LRI in China was 2 853.31/100 000, the age-standardized rate of DALY was 347.67/100 000, and the age-standardized mortality rate was 14.03/100 000. Compared with 1990, the AAPC were −2.13%, −6.89% and −4.10% respectively. In contrast, during the COVID-19 pandemic, both showed a decreasing and then increasing trend, except for the age-standardized incidence rate, which showed a decreasing trend. Children under 5 years of age have experienced the greatest reduction in the burden of disease over the past decades, while the burden of disease has increased in absolute terms for the elderly over 70 years of age. Compared with 1990, the disease burden of LRI in China due to each pathogenic microorganism has decreased. And during 2019−2021, all pathogens showed an increasing trend, except for ASMR caused by influenza (APC=−55.21%) and respiratory syncytial virus (APC=−53.35%). In 2021, the primary attributable risk factors for LRI mortality in China shifted from household air pollution due to solid fuels, childhood underweight, and childhood stunting in 1990 to ambient particulate matter pollution, smoking, and secondhand smoke. Conclusion The disease burden of LRIs in China showed an overall decreasing trend from 1990 to 2021, but with large variations between age groups and pathogens. During the two years following the outbreak of the COVID-19 pandemic, the incidence of LRI in China, along with the disease burden caused by influenza and respiratory syncytial virus, significantly declined. Over the past few decades, the attributable risk factors for mortality and DALYs have undergone substantial changes. To address this phenomenon, targeted measures should be implemented to reduce the burden of LRI on the population caused by air pollution and smoking.

Citation： GUO Heng, ZHU Shuaijie, SHI Wei, ZHANG Xiaoyu, HUA Tianfeng, YANG Min. Disease burden of non-COVID-19 lower respiratory infection in China, 1990−2021. Chinese Journal of Evidence-Based Medicine, 2025, 25(3): 256-264. doi: 10.7507/1672-2531.202406146 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Guidelines for diagnosis and treatment of Chinese medicine on idiopathic pulmonary fibrosis

  • Next Article

    Trends in hospitalization expenses of PCI surgery for coronary heart disease patient based on double breakpoint interrupt time series analysis